Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/02/2014 | CN102379846B 以氢氟烷烃和聚乙二醇为辅料氟替卡松丙酸酯气雾剂制剂 With HFA and polyethylene glycol as adjunct fluticasone propionate aerosol formulation |
07/02/2014 | CN102342951B 繁缕黄酮苷类提取物、其制备方法及制药用途 Chickweed flavonoid glycoside extracts, their preparation and pharmaceutical use |
07/02/2014 | CN102307860B Gpr120受体激动剂及其用途 Gpr120 receptor agonists and their use |
07/02/2014 | CN102295744B 作为抗感染药的表面两亲聚合物 As anti-infective surface amphiphilic polymers |
07/02/2014 | CN102292320B 作为glyt-1抑制剂的芳酰基氨基-和杂芳酰基氨基-取代的哌啶类 As glyt-1 inhibitor aroylamino - and heteroaryl-acyl amino - substituted piperidines |
07/02/2014 | CN102286026B 无环核苷酸类似物的盐及其晶型和药物组合物 Salts and polymorphs and pharmaceutical compositions of acyclic nucleotide analogues |
07/02/2014 | CN102274285B 一种用于2型糖尿病及并发症的药物组合物 Pharmaceutical composition for type 2 diabetes and complications |
07/02/2014 | CN102274164B 帕潘立酮及帕潘立酮衍生物的注射用缓释凝胶剂 Injectable sustained-release gel Paliperidone and Paliperidone Derivatives |
07/02/2014 | CN102260184B 丙泊酚衍生物及其制备方法和应用 Propofol derivative and preparation method and application |
07/02/2014 | CN102258469B 一种奥昔布宁醇质体组合物及其制备方法 One kind of oxybutynin ethosomes composition and its preparation method |
07/02/2014 | CN102245607B 吗啉代嘌呤衍生物 Morpholino purine derivative |
07/02/2014 | CN102241627B 脲类化合物及其医药用途 Urea compounds and their pharmaceutical use |
07/02/2014 | CN102229606B 含异噁唑杂环的2-甲基苯并呋喃类衍生物及制备与应用 2-containing heterocyclic isoxazole derivatives and preparation and application methylbenzofuran class |
07/02/2014 | CN102229603B 含三唑杂环的2-甲基苯并呋喃类化合物及其制备与应用 Triazole-containing heterocyclic compounds and their preparation and application 2- methyl benzofuran |
07/02/2014 | CN102218027B 一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂 One kind of poorly soluble anticancer drugs entrapped polymer micelle lyophilized preparation |
07/02/2014 | CN102212008B 丹参素川芎嗪衍生物及其制备方法和应用 Danshensu TMP derivatives and preparation method and application |
07/02/2014 | CN102209713B 作为5-羟色胺-6配体的1-(芳磺酰基)-4-(哌嗪-1-基)-1h-苯并咪唑 As the serotonin ligand -6 1- (arylsulfonyl) -4- (piperazin-1-yl) -1h--benzimidazole |
07/02/2014 | CN102186473B 用于治疗周围神经病的化合物 Compounds for the treatment of peripheral neuropathy |
07/02/2014 | CN102176906B Panduratin衍生物或提琴形凹唇姜提取物的全新用途 The new use of Panduratin derivative or the Boesenbergia pandurata extract of |
07/02/2014 | CN102159093B 磷脂降低含有酚类化合物的组合物的收敛性的用途 Reduce the astringency of the phospholipid-containing composition of phenolic compounds |
07/02/2014 | CN102153575B 二氧六环参与配位的稀土配合物及其制备方法和用途 RE dioxane ligand complexes involved in its preparation and use |
07/02/2014 | CN102137862B 作为nadph氧化酶抑制剂的吡唑并吡啶衍生物 As nadph oxidase inhibitors pyrazolo pyridine derivatives |
07/02/2014 | CN102137682B 抗丙型肝炎病毒组合物 Anti-hepatitis C virus composition |
07/02/2014 | CN102124012B 可作为丙型肝炎病毒抑制剂的大环吲哚衍生物 Can be used as inhibitors of hepatitis C virus macrocyclic indole derivatives |
07/02/2014 | CN102119152B 有机化合物 Organic compounds |
07/02/2014 | CN102108092B 23-羟基白桦酸衍生物及其制备方法和用途 23-hydroxyl betulinic acid derivatives and their preparation and use |
07/02/2014 | CN102099357B 用于治疗代谢障碍的甲酰胺化合物 For the treatment of metabolic disorders carboxamide compounds |
07/02/2014 | CN102099009B 氟喹诺酮类的肺部递送 Fluoroquinolones pulmonary delivery |
07/02/2014 | CN102093421B 一种含磷取代基的喹啉类化合物及其制备方法、以及含有该化合物的药物组合物及其应用 Quinoline compounds and a method for preparing a phosphorus-containing substituent, and the pharmaceutical compositions containing the compounds and uses thereof |
07/02/2014 | CN102065858B 使用唑尼沙胺和阿坎酸治疗阿尔茨海默病和相关病症的组合组合物 Use of zonisamide and acamprosate treatment of Alzheimer's disease and related disorders, a combination thereof |
07/02/2014 | CN102048695B 一种制备用于体内递送药理活性物质的蛋白纳米粒的方法 In vivo delivery of a pharmacologically active substance a method for preparing protein nanoparticles |
07/02/2014 | CN102046208B 包含转录因子诱饵作为活性成分的用于外部应用的组合物 Containing the transcription factor decoy as an active ingredient of compositions for external application |
07/02/2014 | CN102018698B 治疗雌激素受体相关疾病的化合物及其方法 Compound of the treatment of estrogen receptor-related diseases and a method |
07/02/2014 | CN102015686B 杂环化合物及其用途 Heterocyclic compounds and their use |
07/02/2014 | CN102015675B 作为凝血因子Xa和凝血酶的抑制剂的氯噻吩-酰胺 As the blood coagulation factor Xa and thrombin inhibitors chloro-thiophene - amide |
07/02/2014 | CN102001959B 一种药物晶体及其制备方法和用途 A pharmaceutical crystal and its preparation and use |
07/02/2014 | CN102001949B 3,5-二甲氧基二苯乙烯衍生物及其制备方法与抗耐药性细菌的应用 3,5-dimethoxy-stilbene derivative and preparation method and application of anti-bacterial resistance |
07/02/2014 | CN101977905B 4-吡啶酮化合物及其对于癌症的用途 4- pyridone compounds and their use for cancer |
07/02/2014 | CN101959405B 治疗糖尿病的氧杂二氮杂蒽化合物 Oxa treating diabetes diaza anthracene compound |
07/02/2014 | CN101938902B 苄基苯基环己烷衍生物及使用方法 Benzyl-phenyl-cyclohexane derivatives and methods of use |
07/02/2014 | CN101917985B 糖基神经酰胺增强对抗原的免疫反应的用途 -glycosylceramides Enhance the immune response to an antigen use |
07/02/2014 | CN101890030B 抗菌、抗病毒、抗氧化及抗色素沉积的组合物 Antibacterial, antiviral, antioxidant and anti-pigmentation composition |
07/02/2014 | CN101889086B Tnf超家族受体的剪接转换寡聚物,以及它们治疗疾病的用途 Tnf receptor superfamily splice conversion oligomers thereof, and their use in the treatment of diseases |
07/02/2014 | CN101869593B 一种化痰消咳片的检测方法 A detection method for eliminating phlegm cough tablets |
07/02/2014 | CN101801192B 拉莫三嗪的口服崩解片剂组合物 Lamotrigine orally disintegrating tablet compositions |
07/02/2014 | CN101784558B 神经甾体化合物 Neural Steroids |
07/02/2014 | CN101784520B 磺酰基丙二酰胺衍生物和其药物用途 Sulfonyl malonamide derivatives and their pharmaceutical use |
07/02/2014 | CN101784516B 作为凝血因子抑制剂的二肽类似物 As a coagulation factor inhibitor dipeptide analogs |
07/02/2014 | CN101679472B 用于预防或治疗病毒感染的化合物及其应用方法 Compound and application method of preventing or treating viral infections for |
07/02/2014 | CN101541346B 包含环状化合物的制剂 Formulation comprising a cyclic compound |
07/02/2014 | CN101478970B 喹喔啉基大环丙型肝炎病毒丝氨酸蛋白酶抑制剂 Quinoxalinyl macrocyclic serine protease inhibitors of hepatitis C virus |
07/02/2014 | CN101474175B 一种高生物利用度非布司他口服固体制剂及其制备方法 A high-bioavailability of oral solid febuxostat and its preparation method |
07/02/2014 | CN101472911B 三取代的1,2,4-三唑 Tri-substituted 1,2,4-triazole |
07/02/2014 | CN101374801B 用于增强抗真菌剂活性的组蛋白脱乙酰酶抑制剂 Histone antifungal agent for enhancing the activity of deacetylase inhibitors |
07/02/2014 | CN101203270B 具有体重再分配性能的物质 Substances with weight redistribution performance |
07/01/2014 | USRE44987 Bromo-phenyl substituted thiazolyl dihydropyrimidines |
07/01/2014 | US8766006 Use of nitroaniline derivatives for the production of nitric oxide |
07/01/2014 | US8766005 Process for producing fingolimod salts |
07/01/2014 | US8765994 Ship 1 modulators |
07/01/2014 | US8765982 Synergistic anticoagulant composition |
07/01/2014 | US8765973 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
07/01/2014 | US8765972 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides with selective PARP-1 inhibition |
07/01/2014 | US8765964 Fatty acid niacin conjugates and their uses |
07/01/2014 | US8765963 Fatty acid niacin conjugates and their uses |
07/01/2014 | US8765960 6-((S)-1- {1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1H-pyrazol-3-YL}-ethyl)-3H-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent AMPA receptor antagonist |
07/01/2014 | US8765959 Piperidine derivatives |
07/01/2014 | US8765956 Nitrogen-containing heteroaryl compounds and methods of use thereof |
07/01/2014 | US8765954 1,8-naphthyridine compounds for the treatment of cancer |
07/01/2014 | US8765949 CCR2 receptor antagonists and uses thereof |
07/01/2014 | US8765944 Compounds for the treatment of hepatitis C |
07/01/2014 | US8765941 Aniline derivative having anti-RNA viral activity |
07/01/2014 | US8765930 RNA interference mediating small RNA molecules |
07/01/2014 | US8765883 Stabilized polymeric thiol reagents |
07/01/2014 | US8765837 Dental curable composition |
07/01/2014 | US8765820 Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LSD2 |
07/01/2014 | US8765819 Composition comprising benzoic acid in combination with organic acid preservatives as active ingredients and the use thereof |
07/01/2014 | US8765818 Tannin formulation for treating GI spasms in a subject having Crohn's disease or ulcerative colitis |
07/01/2014 | US8765817 Selective inhibitors of EG5 motors and methods of use |
07/01/2014 | US8765816 Inhibitors of cognitive decline |
07/01/2014 | US8765815 N-phenyl anthranilic acid derivatives and uses thereof |
07/01/2014 | US8765814 N-hydroxyformamide derivative and medicament containing same |
07/01/2014 | US8765813 Use of treprostinil to treat and prevent ischemic lesions |
07/01/2014 | US8765812 Therapeutic compounds |
07/01/2014 | US8765810 Tumor necrosis factor inhibitors |
07/01/2014 | US8765808 Treatment or prevention of cancer and precancerous disorders |
07/01/2014 | US8765807 Esters of capsaicin for treating pain |
07/01/2014 | US8765805 Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof |
07/01/2014 | US8765804 Pharmaceutical compositions comprising lignans and their derivatives for treating hyperplastic diseases |
07/01/2014 | US8765802 Kinase inhibitors, compositions thereof, and methods of use therewith |
07/01/2014 | US8765801 Polymorphs of azabicyclohexane |
07/01/2014 | US8765800 Crystalline (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine |
07/01/2014 | US8765799 Streptospirole derivatives |
07/01/2014 | US8765798 Peptide derivatives with therapeutic activity |
07/01/2014 | US8765797 TG2 inhibitors and uses thereof |
07/01/2014 | US8765796 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
07/01/2014 | US8765795 Isothiazolone-containing preservative with improved effectiveness |
07/01/2014 | US8765794 Compositions and methods for wound care |
07/01/2014 | US8765793 Compositions with skin benefit compounds and chelator stabilized cationic ammonium compounds |
07/01/2014 | US8765792 Indoles |
07/01/2014 | US8765791 Method of treating cancer using a neuropeptide Y 5R (NP Y5R) antagonist |